Indications
Treatment of diabetes mellitus in adults.
Composition
- Active substance
- insulin degludec
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Tresiba
- Active substance
- insulin degludec
- ATC code
- A10AE06
- Therapeutic area
- Diabetes Mellitus
- Marketing authorisation holder
- Novo Nordisk A/S
- Status
- Authorised
- EU authorisation
- 20 Jan 2013
- EMA product number
- EMEA/H/C/002498